WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

After several days and sleepless nights, members of the World Trade Organisation (WTO) finally agreed several key trade initiatives last week, including one that promises to suspend patent protection of the COVID-19 vaccines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Asia

China’s medtech shake-up forces rethink on pricing, IP and innovation

3 July 2026 A report warns that procurement reforms in Mainland China, alongside the rise of open robotics platforms, supply chain disruption and GLP-1 drugs, are challenging existing medtech business models.

Americas

LSD trade secrets suit over clinical trail info thrown out by judge

2 July 2026 A federal court has ruled in a dispute between a clinical trial technology company and a psychedelic drug developer over allegations of trade secret misuse during a bidding process.

Careers

HGF expands European offering with pair of in-house hires

2 July 2026 The firm has appointed two new partners in Basel and Bristol, adding decades of expertise from the pharmaceutical and biotech sectors to its growing life sciences practice.

More features

Pfizer’s US Paxlovid patent fight turns on a single error

GLP-1 patents and Africa: The COVID-19 lessons we still have not learned

Moderna: BioNTech is claiming work ‘it never did’

Heated LNP litigation puts Moderna and Acuitas in the spotlight

Moderna loses key mRNA patent in European vaccine fight

CureVac targets Moderna with 10-patent suit over Spikevax

Patent office fee increases: What applicants must know

IndiaMart v CDSCO: A test of intermediary liability

WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

More on this story

Editor's picks

Editor's picks

More features